Cosolutes Modulate Polyubiquitin Fibrillation Authors: Kalpaja Acharya, Sri Rama Koti Ainavarapu, Ranabir Das Published: 2026 ABSTRACT Ubiquitin, a 76-residue polypeptide, functions as a post-translational modifier and forms polyubiquitin (polyUb) chains on substrate proteins to activate diverse cellular functions. Ubiquitin is often found in the lesions associated with neurodegenerative disorders like Alzheimer’s and Huntington’s disease. It was recently observed that polyubiquitin chains, under in vitro conditions, often form β-sheet-rich fibrillar amyloid aggregates. However, the exact mechanism of conversion from monomer polyUb to amyloid-like fibrils is poorly understood. We report that polyubiquitin forms higher-order oligomeric fibrils and temperature, pH, and ionic strength modulate polyubiquitin (polyUb) fibrillation. Cosolutes such as ionic liquids and macromolecular crowding agents also enhance the aggregation rate. These findings uncover that temperature/cosolutes lower the energy barrier to populate a partially unfolded form (M*), which drives amyloid-like fibril formation. Other factors increase the effective protein concentration of these partially unfolded forms, accelerating aggregation. These insights provide the fundamental basis for ubiquitin chain aggregation, which is necessary to guide the development of therapies and diagnostics. Introduction Cellular proteostasis represents a critical defense mechanism against protein misfolding and aggregation, employing hierarchical quality control systems to maintain proteome integrity. Central to this regulation are molecular chaperones, which facilitate the refolding of misfolded proteins to their native conformations. If the refolding mechanism fails, the ubiquitin-proteasome system (UPS) selectively tags and degrades misfolded proteins. However, under certain conditions, misfolded proteins evade the UPS, whereby the exposed hydrophobic residues promote aberrant intermolecular interactions to form aggregates. While autophagy targets these aggregates for lysosomal clearance, prolonged aggregate overload can overwhelm cellular degradation capacity. , This allows the structural reorganization of aggregates into β-sheet-rich amyloid fibrils, which are stable and resistant to cellular clearance mechanisms. These amyloids disrupt cellular homeostasis and critical neuronal functions, including mitochondrial maintenance, receptor trafficking, and DNA repair. As a result, amyloid accumulation in neurons can lead to the onset and progression of various neurodegenerative disorders. , In neurodegenerative diseases such as Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s disease (HD), ubiquitin-positive amyloid deposits are a hallmark pathological feature observed in affected brain tissues. − These lesions, formed by aggregation-prone neurotoxic proteins such as β-amyloid, tau, and α-synuclein, are closely associated with the dysregulation of the UPS. , Additionally, linear polyUb chain aggregates were detected in ALS-associated lesions. Understanding the mechanisms underlying the formation of ubiquitin-positive amyloids is therefore crucial for understanding their role in neurodegeneration and for developing therapeutic strategies. Ubiquitin is a small protein composed of 76 amino acids that plays a vital role in regulating diverse cellular processes in eukaryotic organisms. Structurally, ubiquitin adopts a β-grasp fold characterized by a tightly packed hydrophobic core and extensive hydrogen bonding, contributing to its remarkable stability. Substrate-specific ubiquitylation is involved in various cellular processes, including immune response, angiogenesis, cell proliferation, apoptosis, and DNA damage repair. The lysine residues (K6, K11, K27, K29, K33, K48, and K63), along with the N-terminal amine group (Linear or M1-linkage) in ubiquitin, can facilitate further elongation of the ubiquitin conjugation, thereby forming polyubiquitin (polyUb) chains. The ubiquitin code, defined by the type and topology of ubiquitin chains, determines specific cellular signals. Inflammation triggers a significant upregulation of M1-linked polyubiquitin chains that are necessary to activate responses such as the NFkB pathway. Prolonged inflammation leads to consistently higher levels of linear polyubiquitin chains, which can seed the formation of protein aggregates, initiating a positive feedback loop linking neuroinflammation to protein aggregation. Ubiquitin maintains a compact, globular fold that resists unfolding across a wide range of pH and temperature. However, within polymeric ubiquitin chains, their stability decreases progressively with increasing chain length, leading to the formation of amyloid-like fibrils. The limited native contacts between ubiquitin moieties and the absence of classic aggregation-prone motifs raise intriguing questions about the molecular drivers of polyubiquitin fibril formation. Here, we systematically identify the aggregation-promoting factors for polyubiquitin and infer the population of a partially unfolded intermediate (M*) that arises from the native state. Taken together, these results provide critical insights into the mechanism of polyubiquitin chain aggregation. Results Thermal Destabilization of Polyubiquitin Chains Drives the Formation of Irreversible, Amyloid-Like Aggregates To assess the effect of thermal destabilization on polyubiquitin chain aggregation, purified M1-linked polyUb chains were heated to 85 °C and monitored by various biophysical techniques (Figure a). The elevated temperature was used to accelerate aggregation. Thermal destabilization of polyubiquitin chains drives formation of irreversible, amyloid-like aggregates. (a) Schematic diagram depicting steps of characterization of amyloid-like aggregates (Created with BioRender.com). (b) Effect of heat on 6 μM mono-, di-, tri- and tetraubiquitin (right to left). The irreversible, fibril-like aggregates settled at the bottom are marked in red. (c) TetraUb was heat-treated at 85 °C, followed by the ThT assay, in which fluorescence was measured using an excitation wavelength of 440 nm and emission at 480 nm, thereby revealing the effect of the initial protein concentration on ThT binding and hence on the aggregation rate. (d,e) Comparative analysis of the effect of chain length on the rate of aggregation. Rates were obtained by fitting the data to a first-order kinetic equation. (f). Effect of pH and salt on the aggregation rate of tetraUb, analyzed at pH 4.0, 8.0, and 11.0. Error bars represent the standard error of the mean in (e) & (f) and the standard deviation in (c), taken from three independent experiments. An unpaired (e) and a paired (f) t test was performed. ns – Not significant * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Heat treatment of polyUb chains (di-, tri, and tetraubiquitin) produced translucent, irreversible aggregates (Figure b), whereas monoUb remained soluble under these conditions. The secondary structure of these fibrillar aggregates was analyzed using far-UV CD spectroscopy. Upon heating, while monoUb retained its secondary structure, polyUb chains lost their α-helical signature and converted to a β-sheet-rich conformation (Supplementary Figures 1, 2, and 3), a hallmark of amyloid-like fibrils. The aggregation of polyUb was consistent with previous reports, which correlate the reduced stability with the aggregation propensity of polyUb. To quantify the kinetics of polyUb aggregation, we used the Thioflavin-T (ThT) assay, which reflected that the polyUb aggregation kinetics are dependent on the initial protein concentration, indicating a first-order kinetic mechanism (Figure c, Supplementary Figure 4a,b). To further assess the kinetic order in our system, initial aggregation rates, obtained from monoexponential fits to ThT fluorescence traces, were plotted against protein concentration on a log–log scale (Supplementary Figure 4b). The resulting slope of 1.63 (R2 = 0.9) supports pseudo-first-order kinetics and suggests a concentration-dependent primary nucleation or oligomerization step preceding fibril elongation. This scaling behavior is consistent with the apparent first-order kinetics observed under our experimental conditions and supports the proposed aggregation mechanism. Similar concentration-dependent behavior has been previously reported, where polyUb aggregation kinetics were successfully described using a first-order kinetic model. A lag phase was not captured within the first 15 s of the reaction, which could be because the lag phase is too short (<1 s). This finding is consistent with ultrafast (<37 μs) conformational fluctuations and partially unfolded intermediates observed during prion protein folding using microsecond mixing and PET-FCS, as well as hyperfast hydrophobic collapse in nucleation–collapse pathways. Rapid-quench experiments could further resolve these transient species. Alternatively, it could be because polyUb aggregation is a nucleation-independent isodesmic process (Figure d). The observed behavior shares certain features with proposed prion aggregation models, characterized by heterogeneous precursor populations and oligomeric intermediates, and involving secondary nucleation and conformational conversion rather than a strictly defined critical nucleus–driven pathway. Longer polyUb chains aggregated faster (Figure d,e), suggesting chain length affects the rate of aggregation, consistent with previous reports. Notably, the equivalent number of monomer ubiquitin units does not aggregate under similar conditions (Supplementary Figure 5), suggesting that aggregation is not driven by the local concentration of ubiquitin alone, but is instead mediated by chain length–dependent avidity effects and a reduction in stability. A gradual decrease in thermodynamic stability with chain length has been observed earlier. We proceeded to study the effect of various solvent conditions and solutes on polyUb aggregation. TetraUb was taken as the “candidate” polyUb chain for further experiments in this work. To determine the effect of pH on polyUb chain aggregation, the aggregation propensity was measured at multiple pH values. Between pH 4, 8, and 11, we observed that the aggregation propensity was highest at pH 8, closely approximating the protein’s isoelectric point of 7.2, where the surface charge is minimal (Figure f). This suggests that intermolecular hydrophobic interactions drive the aggregation of tetraUb chains into amyloid-like structures. Similar behavior has been observed in classically amyloidogenic proteins, such as α-synuclein. As the pH deviated from the pI (i.e., pH 4 or 11), the aggregation rate decreased, likely due to increased intramolecular electrostatic repulsion between surface charges. Salt (150 mM NaCl) at low pH accelerates Prion oligomerization. For polyUb, salt has a subtle enhancement effect at pH 8. At pH 4 and 11, salt enhanced aggregation significantly, suggesting that it screens charges to mitigate electrostatic repulsion, promotes hydrophobic interactions and aggregation (Figure f and Supplementary Figure 6). Polyubiquitin (PolyUb) “Fibrils” Exhibit Oligomeric Organization To understand the fibrillation mechanism of polyUb chains, we studied the different states of polyUb fibrils using mass photometry (MP), a single-molecule interferometric imaging technique. MP detected the size of individual polyUb molecules via light interference, enabling precise mass measurement based on optical contrast variations. Tetraubiquitin (tetraUb) existed as a monomer (34 kDa) at room temperature (Figure a). However, upon heat treatment, followed by rapid cooling to room temperature additional peaks corresponding to multimeric forms of tetraUb emerged in the solution (Figure b), suggesting that the polyubiquitin chains, upon heating, can oligomerize to form fibrils. Since untreated tetraUb does not oligomerize, these oligomers may arise from a putative M* intermediate state induced by heat treatment of tetraUb. Polyubiquitin chains oligomerize to form amyloid-like aggregates with a spherical morphology. Tetraubiquitin chains (tetraUb) were subjected to Mass Photometry (MP) under untreated (a) and heat-treated conditions (b). The emergence of various oligomerization states is represented by gray elliptical structures, each corresponding to a specific molecular mass. To obtain morphological information about these different oligomeric states, Atomic Force Microscopy (AFM) images (c,d,e) of polyubiquitin fibrils, along with untreated TetraUb (negative control), Mouse Prion oligomer (positive control), were obtained using Park Systems NX-10 in noncontact mode. The scale on the extreme left represents the sample’s z-height. The individual z-height (marked in red) was quantified and plotted (Z vs X plot) for further analyses. To characterize the structural properties of tetraUb aggregates, atomic force microscopy (AFM) was performed in noncontact mode. The aggregates exhibited a distinct spherical morphology (Figure c,d,e), resembling the oligomeric structures observed in mouse Prion proteins under acidic conditions (pH 4, 150 mM NaCl). Further analyses revealed that the z-heights of tetraUb fibrils ranged from 3 to 8 nm, comparable to those of mouse Prion oligomers (Figure c). The topographic similarity suggests that Prion and tetraUb aggregates share mesoscopic structural features. It is also important to note that mouse Prion oligomers, at certain conditions, exhibit a monophasic growth curve, governed by first-order kinetics, similar to tetraUb (Figure c). Our data indicate that polyUb fibrils aggregate via an analogous mechanism, where monomeric units progressively oligomerize to form mature fibrils. Taken together, these analyses indicate that assemblies previously described as fibrils predominantly correspond to “oligomeric”, protofibril-like structures, which may give rise to the formation of mature, “amyloid-like fibrils”. For clarity and consistency with prior literature, we retain the term “fibrils” to describe these oligomeric species throughout this study. Polyubiquitin Chain Aggregation is Temperature-Dependent To explore the impact of lower temperatures on polyUb aggregation, we performed aggregation experiments at 65 °C. At the lower temperature, polyUb chains form β-sheet-rich amyloid-like fibrils (Figure a), as confirmed by Thioflavin-T fluorescence and CD spectroscopy (Figure b,c,d). Polyubiquitin chain destabilization is thermodynamically as well as kinetically regulated by temperature. (a) Effect of temperature on tetraubiquitin (tetraUb) before (left) and after treatment at 65 °C (right). The irreversible, fibril-like aggregates settled at the bottom are marked in red. (b) Thioflavin-T fluorescence of tetraubiquitin was observed at increasing protein concentrations. (c,d) CD spectra of tetraubiquitin without and with heat-treatment, respectively. (e) Effect of initial monomer concentration on the aggregation rate. For lower temperatures, the initial rates were obtained by fitting the data to the linear equation y = mx. Error bars represent standard error of mean taken from three independent experiments. A paired t-testt test was performed. ns – Not significant* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. (f) The rates of aggregation were calculated at different temperatures (75, 65, and 50 °C and the activation energy was calculated. The slope was −40.8 ± 10.3, which led to the activation energy of 81.5 ± 20.5 kcal/mol. The measurement of aggregation kinetics revealed that fibril formation follows a first-order kinetic model at lower temperatures, suggesting a similar aggregation mechanism (Figure b,e; Supplementary Figure 4). To measure the activation energy, we measured the aggregation rate at various temperatures (Figure e, Supplementary Figure 7). The Arrhenius fit of the aggregate rates against temperature yielded an activation energy of 81.5 ± 20.5 kcal/mol (Figure f), which is substantially higher than reported nucleation barriers for most amyloidogenic proteins (∼10–50 kcal/mol), including Prion (∼30 kcal/mol), but comparable to natively folded amyloid-formers like β2-microglobulin (160 kJ/mol) and lysozyme (250 kJ/mol). , These observations suggest that polyubiquitin assemblies may accumulate over extended periods under physiological conditions. Cosolutes Modulate Polyubiquitin Aggregation Rates Cosolutes can significantly influence protein stability in solution, thereby affecting their propensity to aggregate. To investigate the role of macromolecular crowding in polyUb aggregation, tetraUb was incubated with 100 mg/mL polyethylene glycols (PEGs) of varying molecular weights (PEG-600 to PEG-20000) (Figure a, Supplementary Figure 8). Kinetics analysis revealed a significant increase in aggregation rate with increasing molecular weight. Furthermore, the rate enhancement was dose-dependent (Figure b, Supplementary Figure 9a), consistent with the excluded volume effect. Cosolutes modulate polyubiquitin aggregation rates through solute-specific interactions. ThT assay showing the effect of TetraUb aggregation (a) in the presence of PEG of different molecular weights measured at 65 °C, (b) in the presence of PEG-20000 at varying concentrations. (c) Aggregation kinetics of 50 μM tetraUb after priming the reaction with preformed seeds (% w/w). (d) Aggregation kinetics of tetraUb at different monomeric concentrations after priming them with preformed seeds (40% w/w). Error bars represent the standard error of the mean taken from three independent experiments. A paired t test was performed. ns – Not Significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. However, the observed effect was evident only at protein concentrations exceeding C*, − indicating that contributions from solution viscosity and protein–protein interactions cannot be excluded. Notably, this enhancement in aggregation was conserved at physiological temperatures of 37 °C (Supplementary Figure 9b). Larger, more abundant PEG molecules consistently enhanced polyUb aggregation rate. To address whether the observed enhancement in aggregation arises from viscosity or macromolecular crowding, control assays were performed using 35% v/v glycerol, which broadly correlates with the solution viscosity of 10% v/v PEG-20,000 ,− but does not generate excluded volume effects. Using the same polyUb protein batch, the ThT assay showed aggregation in the presence of PEG-20,000, whereas no aggregation was detected under glycerol conditions (Supplementary Figure 9c). These results indicate that the enhanced aggregation observed in PEG-20,000 is not driven by viscosity but is consistent with excluded volume effects arising from macromolecular crowding. Collectively, these observations indicate that macromolecular crowding enhances aggregation primarily by increasing the effective local concentration of M*. Amyloid fibrils demonstrate seeding behavior. To determine whether polyUb fibrils show seeding activity, tetraUb was incubated with preformed amyloid-like “seeds” in aggregation assays. These preformed aggregates caused a modest increase (1.4-fold change) in the aggregation rate, suggesting that priming the reaction with a “template” moderately facilitates aggregation (Figure c). Notably, the aggregation was also influenced by the initial concentration of PolyUb chains, indicating that the seeding mechanism resembles that of the primary aggregation pathway (Figure d). Since the tetraUb aggregation lacks a lag phase and proceeds via nucleus-independent kinetics, seeding primarily enhances template elongation rather than nucleation. The seeding-like behavior of polyUb fibrils may explain the frequent incorporation of ubiquitin into amyloid plaques in neurodegenerative disorders. , Together, these observations highlight a nuanced role of cosolutes, influencing both association and elongation steps of the aggregation process. Ionic Liquids (ILs) Modulate Global Stability and Aggregation Rates of Polyubiquitin Chains Ionic liquids (ILs) are considered promising media for biocatalysis due to their unique characteristics, including nonvolatility, flame resistance, and tunable polarity and water miscibility. Recent studies have shown that ionic liquids (ILs) exhibit substantial biological relevance, increasing use as biocompatible solvents, protein stabilizers, and drug delivery platforms. Biocompatible ILs, including cholinium-based salts such as [Ch]­Cl, interact with proteins and surrounding water via hydrogen bonding, leading to enhanced thermal stability, reduced aggregation, and altered folding equilibria. Imidazolium-based ILs, such as [BMIM]­[BF4] and [EMIM]­[Cl], are known to modulate protein stability through adjustable chaotropic–kosmotropic behavior. The ability of ILs to destabilize or stabilize native protein states underscores their biological significance, as subtle shifts in protein conformational equilibria can strongly influence aggregation propensity and functional outcomes in cellular systems. However, their unique physicochemical properties may alter the native conformation of biomolecules, potentially reducing their stability. Recent studies have demonstrated that imidazolium-based ILs like [BMIM]­[BF4] lower the unfolding barrier of the ubiquitin energy landscape without affecting the structures of transition states. We investigated whether IL affects the aggregation properties of polyubiquitin chains. The results indicated that IL-mediated destabilization significantly accelerated polyUb aggregation, exhibiting a pronounced dose-dependent effect (Figure a,b, Supplementary Figure 10a). Ionic Liquids Modulate Global Stability and Aggregation rates of Polyubiquitin chains. (a) ThT assay showing aggregation kinetics of tetraUb chains observed at 65 °C in the presence of the ionic liquid BMIM­[BF4]. (b) The rates obtained from (a) are fitted and plotted as bar graphs. Error bars represent the standard error of the mean. A paired t test was performed. ns – Not Significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. (c) NMR Chemical shift perturbations (CSPs) were quantified and plotted against tetraUb residues. Chemical shift perturbation (CSP) was calculated for each residue after every titration point using the equation, CSP = [(δNfree – δNbound)/5)­2 + (δHfree – δbound)­2]­1/2, where δH and δN denote amide hydrogen and nitrogen chemical shifts, respectively, in the presence and absence of ligand. Dashed lines represent the thresholds beyond which CSPs were considered significant. The black line marks residues with CSPs above the Mean + SD. The red line marks residues with CSPs above the Mean +2SD. (d) Residues showing significant perturbations beyond these thresholds were mapped onto the ubiquitin structure. To obtain high-resolution information about polyUb-IL interaction, we performed an NMR titration of 15N-labeled tetraUb at pH 7.4 with increasing concentrations of [BMIM]­[BF4], acquiring heteronuclear single quantum coherence (HSQC) spectra at each titration point (Figure c; Supplementary Figure 10b,c). The titration data were fitted to a 1:1 protein–ligand binding model, yielding a dissociation constant (Kd) of 312 ± 24 mM (Supplementary Figure 11). The Kd suggests that the interaction between tetraUb and [BMIM]­[BF4] is weak, consistent with that of monoUb with [BMIM]­[BF4]. The ΔCSP values in the presence and absence of [BMIM]­[BF4] suggest that the IL interacts with mostly polar and charged side chains. Specifically, the salt-bridges K11-E34 and K27-D52 are perturbed by [BMIM]­[BF4] (Figure d). To examine whether the salt-bridge destabilization observed in the presence of the IL arises from specific interactions or from a nonspecific bulk solvent effect, the protein was titrated with glycine at comparable molar concentrations. Chemical shift perturbation (CSP) analysis showed that the shifts for polar residues remained within the mean range of the overall residue distribution, indicating no significant perturbation in the presence of glycine (Supplementary Figure 12). This confirmed that the destabilization is driven by specific interactions associated with the IL. Overall, the findings highlight the critical role of protein-IL interactions in modulating the aggregation kinetics of polyUb chains. The NMR chemical shifts of tetraUb suggest subtle changes in the protein, but not global unfolding either at 65 °C or in the presence of [BMIM]­[BF4]. However, the tetraUb aggregation is significantly accelerated by the addition of [BMIM]­[BF4]. Collectively, these results indirectly indicate that IL-induced destabilization may populate the partially unfolded M* intermediate, which drives aggregation. In contrast, monoUb has higher stability than polyUb, and the M* state is not populated under thermal or ionic conditions, likely preventing its aggregation. Discussion During inflammation, a significant portion of the cellular ubiquitin pool is composed of unanchored, M1-linked polyubiquitin (polyUb) chains. These chains play a crucial role in mediating immune responses by activating the NF-κB pathway. Despite their importance, the fate of unanchored polyUb chains remains unclear, particularly under conditions of inflammation and cellular stress. These chains are typically cleaved by deubiquitinating enzymes (DUBs) and recycled back into the cellular monoubiquitin pool. However, during prolonged inflammation or potential downregulation of DUBs, these unanchored chains may aggregate into amyloid-like fibrils. In this work, we present a mechanistic framework describing how native polyUb chains access aggregation-competent states and convert into cross-β–rich assemblies, providing insight into the early steps of polyUb aggregation. We propose that native polyUb chains exist in equilibrium with a higher-energy M* intermediate state, characterized by a partially unfolded conformation. The populations of this M* state can be enhanced by environmental factors such as elevated temperature and cosolutes, including ionic liquids, thereby promoting aggregation. The high activation energy (∼335 kJ/mol) for ubiquitin aggregation reflects the exceptional stability of the native ubiquitin fold, which gates fibrillation. This high barrier aligns with literature precedents for natively folded amyloid-formers like β2-microglobulin (160 kJ/mol) and lysozyme (250 kJ/mol). , An activation energy of 118 kJ/mol was reported for the dissociation of ubiquitin intermediates, comparable to that of Aβ42 protofibril dissociation. This energetic symmetry supports a reversible kinetic framework in which aggregation and dissociation are governed by the same dominant barriernamely, the unfolding of native ubiquitin to populate the partially unfolded M* state. PolyUb aggregates seemingly resemble Prion oligomers in both morphology and monophasic aggregation kinetics, despite lacking significant sequence homology. Structurally, the Prion protein C-terminal domain is α-helix-rich, and the N-terminal domain is disordered. Whereas polyUb is β-sheet-rich with a single α-helix. Therefore, shared aggregation properties may arise from analogous tertiary and intermolecular interactions rather than from sequence or secondary-structure conservation. Nevertheless, the environmental and molecular mechanisms driving aggregation in Prions and polyUb may differ. For example, Prion aggregates rapidly at low pH, because critical interactions within its structure are disrupted at lower pH. Alternatively, α-synuclein and polyUb have the highest aggregation rates near their isoelectric point (pI), suggesting that polyUb aggregation is primarily driven by intermolecular hydrophobic interactions rather than by pH-induced unfolding. Cosolutes profoundly influence protein stability and aggregation propensity in solution. Kinetic analysis showed marked rate acceleration with increasing PEG molecular weight, alongside dose-dependence. This enhancement occurred at concentrations exceeding the PEG critical overlap concentration (C* ≈ 50–80 mg/mL for PEG-20000 − ), where individual polymer coils begin to overlap, forming an interpenetrating network. Thus, as viscosity increases nonlinearly above C* due to chain overlap, diffusional and microviscosity effects may also contribute to the observed kinetics. The absence of aggregation in 35% (v/v) glycerol, despite its viscosity being comparable to that of 10% (v/v) PEG-20,000, indicates that bulk viscosity alone does not influence polyUb aggregation under these conditions, suggesting that the enhanced fibrillization observed in PEG arises from macromolecular crowding rather than viscosity- or diffusion-limited processes. Also, the stringent molecular weight and concentration scaling implicates dominant crowding, conserved even at physiological 37 °C. Taken together, crowding primarily amplifies the effective local concentration of the aggregation-prone intermediate M*, suggesting cellular environments could pathologically accelerate polyUb aggregation despite slower native kinetics. When we investigated the effect of preformed polyUb seeds on the aggregation rate, we observed a modest, dose-dependent increase. This suggests that the primary effect of seeding in polyUb was to enhance template elongation rather than shortening the nucleation phase. It can be speculated that seeds may have a modest effect on stabilizing the M* intermediate, possibly by serving as templates for interactions. The impact of seeding is common between Prions and polyUb, both of which have a short nucleation phase, but distinct from Aβ and α-synuclein kinetics, which have a more extended nucleation phase. Beyond their emerging applications in biotechnology and medicine, ionic liquids provide a useful framework for understanding how tunable solvent environments influence protein stability and aggregation. Biocompatible ILs, such as cholinium-based salts, emulate osmolyte-like behavior by engaging in hydrogen bonding with proteins and water, thereby stabilizing folded states and suppressing aggregation pathways relevant to amyloid-associated disorders. Conversely, imidazolium-based ILs, including [BMIM]­[BF4] and [EMIM]­[Cl], introduce controlled chaotropic or hydrophobic perturbations that reshape protein energy landscapes. In a cellular context, ILs may be viewed as model cosolutes that mimic aspects of the crowded, polyelectrolyte-rich intracellular milieu, where high ionic strength, weak electrostatic screening, and hydrophobic interactions collectively regulate protein conformational stability. Thus, the capacity of ILs to modulate protein folding and aggregation holds direct biological relevance, offering mechanistic insight into how subtle environmental changes can shift proteins toward functional or pathological states. The ionic liquids (IL) enhanced polyUb aggregation rates by lowering the barrier to misfolding. NMR titration experiments suggest IL destabilizes specific salt bridges central to ubiquitin’s native fold. The salt bridges in ubiquitin are crucial for tethering the central helix to the β sheet, thereby maintaining the integrity of the hydrophobic core. IL perturbs the salt bridges, which would loosen the helix, creating partially unfolded forms with exposed hydrophobic residues, promoting intermolecular steric-zipper interactions and leading to rapid large-scale aggregation. In the native structure, the loop between β strands β3 and β5 folds on ubiquitin’s hydrophobic buried core, which is stabilized by the E24-D52 salt bridge. This loop partially unfolds into a higher-energy intermediate state in the ubiquitin folding pathway, , which could potentially correspond to the M* state of polyubiquitin chains. This partial destabilization, particularly involving β-strand and α-helical regions, is predicted to expose aggregation-prone hydrophobic patches. We speculate that hydrophobic faces of β-strands, including residues I3, I13, L67, and H68, may engage in steric zipper–like interactions, while fraying of adjacent polar regions (e.g., K6 and K29) could facilitate close intermolecular approach and oligomer formation. , However, the exact structure of the M* requires further investigation. Consistent with this interpretation, the weak IL–protein affinity supports a denaturant-like mechanism in which ILs increase the population of the aggregation-prone M* state without requiring high-affinity interactions. A similar mechanism was observed in Prions, where weak interactions with NaCl enhance Prion aggregation rate by several-fold. Conclusion Taken together, our data support a model in which the amyloid-like aggregation of polyubiquitin chains is governed by thermal energy, surface electrostatics, molecular crowding, and chemical destabilization. These factors appear to alter the aggregation kinetics by shifting the conformational equilibrium toward a partially unfolded intermediate (M*), thereby facilitating template-assisted elongation and fibril growth, eventually leading to the formation of amyloid-like “fibrils” (Figure ). The aggregation of these partially unfolded forms is further enhanced by surface electrostatics and macromolecular crowding, finally leading to fibril formation. Studying the dynamics of polyubiquitin chain aggregation is thus essential for understanding its potential impact on human health and aging. Proposed model of polyubiquitin (polyUb) aggregation. A schematic diagram depicting different steps of polyUb fibrillation. (Created with BioRender.com). Materials and Methods Expression and Purification of Proteins The clones (mono-, M1-linked di-, tri-, and tetraubiquitin) in the pET3a vector were transformed into BL21 (DE3) bacterial cells and grown in Luria–Bertani (LB) broth for 8–10 h. This culture was used to inoculate a litre of the same LB. The culture was induced at an OD600 of 0.6 with 1 mM IPTG and further incubated at 37 °C for 4–5 h. Cells were pelleted, resuspended in 50 mM Tris-HCl with 150 mM NaCl (pH 8.0), sonicated, and centrifuged. Then, the supernatant was heat-treated at 50–55 °C for 20 min, followed by centrifugation. Finally, the supernatant was collected, and an equal volume of 50 mM Acetate Buffer (pH 4.0) was added, followed by another centrifugation step. Bound proteins on HiTrap SP HP cation exchange column were eluted with a salt gradient of 0–500 mM NaCl. For 6X His-tagged tetraUb, the culture was incubated at 25 °C for 10 h after induction. Then the cells were pelleted, resuspended in lysis buffer (50 mM Tris, pH 8.0, 500 mM NaCl, 20 mM Imidazole), sonicated, and centrifuged. Bound proteins on the HiTrap Ni2+-NTA column were eluted using 0–500 mM Imidazole. The fractions were pooled and further purified by size-exclusion chromatography on a Superdex 75 column (GE Healthcare) in phosphate-buffered saline (1X PBS), pH 7.4. The protein fractions were then pooled, concentrated, flash-frozen in liquid N2, and stored at −20 °C. Protein concentrations were determined by absorbance at 280 nm. The full-length, recombinant moPrP protein was purified as previously described. Preparation of Buffers and Reagents All reagents used in this study were of the highest purity grade and procured from Sigma-Aldrich. For aggregation assays, proteins were diluted in 1× phosphate-buffered saline (PBS; pH 7.4), unless otherwise stated. Final protein concentrations were typically 6 μM for experiments conducted at 85 °C and 50 μM for those at 65 °C, except where specified for concentration-dependent studies. For pH-dependent aggregation assays, proteins were diluted into one of the following buffers: 50 mM sodium acetate (pH 4.0), 50 mM Tris-HCl (pH 8.0), or 50 mM CAPS (pH 11.0), with or without the addition of 150 mM NaCl, as indicated. Aggregation Studies For aggregation studies, diUb and tetraUb were transferred into a tube on the incubator preset to the desired final temperature (85, 65, 50, or 37 °C) for various experimental conditions. For the assays done at 85 °C, 6 uM protein was taken. For the assays performed at 75 °C and lower (65,50 or 37 °C), 50 uM protein was used. The samples were heat-treated for pre-steady state and kinetic measurements, and aliquots were taken, and the aggregation reaction was immediately quenched on ice before further analyses. Optimisation of Amyloid-Like Seeds 100 μM tetraUb was heat-treated at 85 °C, then cooled gradually. The fibrils were desiccated, resuspended in Milli-Q water, and finally homogenized by sonication (5 s on/off, 20% amplitude, 1–2 min). The seeds were stored at 4 °C and added % w/w to the samples for further experiments. Circular Dichroism (CD) Spectroscopy CD measurements were performed on a Jasco J-1500 spectropolarimeter, and spectra were recorded from 250 to 200 nm at 0.1 nm intervals. Spectrum was acquired at 25 °C with a 1 mm path length in sodium phosphate buffer (pH 7.4). The final concentration of all protein samples heated to 85 °C was 30 μM; for 65 °C, it was 50 μM. Data were reported as millidegrees. The buffer’s spectral contributions were subtracted in each case. The percentage of secondary structure conversion was further analyzed using the BeStSEL software. Thioflavin T (ThT) Assay Thioflavin T solution was added from the 2 mM stock to the protein sample to achieve a final concentration of 25 μM. For the assay at 85 °C, a final protein concentration of 6 μM was used; for lower temperatures (65 and 37 °C), a final concentration of 50 μM was used. Fluorescence spectra were acquired using a Fluoromax-3 spectrofluorimeter (Jobin Yvon). The experimental settings used were as follows: excitation wavelength, 440 nm; emission wavelength, 480 nm; excitation bandwidth, 5 nm; and emission bandwidth, 5 nm. The emission spectra of 25 μM ThT in buffer were obtained, and fold changes were calculated for each sample. The kinetic data were fitted to the first-order kinetic equation y = a (1 - exp­(-b*x)) using OriginLab software (where b is the rate constant), and the initial rate was calculated accordingly. Each experiment was repeated three times. The R2 value for each plot was within the range of 0.8–0.9. Atomic Force Microscopy For atomic force microscopy (AFM) analysis, the fibril-containing solution was diluted in 1X PBS (pH 7.5) such that the final concentration of the fibrils was 3 μM. Then, a 6 μL aliquot was deposited onto freshly cleaved mica and incubated for 1.5 min. The mica surface was then rinsed three times with 5 mL of Milli-Q water, thoroughly air-dried, and imaged using a Park Systems NX-10 AFM operating in noncontact mode. Image processing and further analysis were performed using Park Systems XEI software (version 4.3.1). NMR Titration Experiments Both protein and ligand stocks were prepared in 50 mM sodium phosphate buffer (pH 7.4) for tetraUb: [BMIM]­[BF4] titration. TetraUb was titrated with 1 M [BMIM]­[BF4] up to 960 mM. A 1H–15N HSQC spectrum was acquired for each titration point at 298 K on a 600 MHz Bruker NMR Spectrometer, followed by processing in NMRPipe and peak assignment in NMRFAM Sparky. Chemical shift perturbation (CSP) was calculated for each residue after every titration point using the equation, CSP = [(δNfree – δNbound)/5)2 + (δHfree – δbound)2]1/2, where δH and δN denote amide hydrogen and nitrogen chemical shifts, respectively, in the presence and absence of ligand. For determining K d, calculated CSPs were fit into a 1:1 protein: ligand model using the equation, Δδobs = Δδmax{([P]t+[L]t+K d) - √([P]t+[L]t+K d)­2- 4­[P]t[L]t}/2­[P]t, where Δδmax represents CSP calculated for the last titration point, and [P]t and [L]t are protein and ligand concentrations at a titration point. Peptide backbone residues were assigned using CSPs calculated from monoUb under similar conditions. Supplementary Material